Embecta Corp.'s Q4 results showed significant net income and EPS growth. Embecta also announced a restructuring plan. See why ...
Some of the key market players operating in the implantable infusion pump market include Medtronic, Flowonix Medical, Intera Oncology, Tandem Diabetes Care, United Therapeutics, ICU Medical, Johnson & ...